Aura Biosciences Inc

NASDAQ:AURA   3:59:50 PM EDT
16.40
-0.10 (-0.61%)
Earnings Announcements

Aura Biosciences Reports Q1 2022 Results

Published: 05/12/2022 20:26 GMT
Aura Biosciences Inc (AURA) - Aura Biosciences Reports First Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights.
Aura Biosciences Inc- As of March 31, 2022, Aura Had Cash and Cash Equivalents and Marketable Securities Totaling $133.3 Million.
Aura Biosciences Inc- Believes Its Current Cash and Cash Equivalents and Marketable Securities Are Sufficient to Fund Its Operations Into 2024.
Aura Biosciences Inc - Qtrly Loss per Share $0.44.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.47

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.